News

Researchers are looking into corneal biomechanics as a means to screen patients for keratectasia. The authors review signal interpretation from a non-contact applanation tonometer as it relates to corneal biomechanical indices such as corneal hysteresis.

Following intrastromal corneal ring sement implantation five years ago for the management of keratoconus, The Journal of Cataract & Refractive Surgery has published long-term follow up results.

LX214, a topical mixed nanomicellar formulation of voclosporin, has completed its Phase 1 human safety and an open-label pilot efficacy study and is being heralded by its maker Lux Biosciences as a promising treatment for dry eye.

Dr Jorge Alio, a valued member of Ophthalmology Times Europe?s Editorial Advisory Board, has been acknowledged by The Cornea Research Foundation of America (CRFA) for his technique using Yag laser treatments to eliminate epithelial ingrowth after Lasik.

Bromfenac to come to Europe

Bromfenac ophthalmic solution will come to Europe when it comes to market thanks to a co-promotion between Bausch & Lomb and CROMA Pharma.

This is the first ESCRS congress for 9-month old company, Technolas, which was formed out of a joint venture between Bausch and Lomb's refractive surgery unit and 20/10 Perfect Vision. The new business was founded to innovate in excimer and femtosecond laser technologies, focusing primarily on the correction of presbyopia.

Schwind unveiled its PresbyMAX software module at ESCRS, a presbyopia solution for its AMARIS system. According to Schwind, the software makes it possible, for the first time, to treat emmetropic as well as myopic, hyperopic and astigmatic patients whose accommodative response is limited.

The Flexivue System, a breakthrough implantable micro-lens treatment for presbyopia from Presbia Coöperatief was unveiled at the show and it is keenly anticipated that it will be in clinical trials in several European countries by the end of the year.

The news broke at today's show that Alcon is to gain access to proprietary antibody fragment technology particularly suited to treat eye diseases with its plan to acquire ESBATech AG, a Swiss biotechnology firm.

Rayner, the world's first IOL manufacturer, unveiled a dynamic new brand identity at ESCRS and held a seminar today to highlight the success doctors are having with its range of toric IOLs. Headlined A Roadmap to Success the seminar featured presentations from seven European doctors relating their experiences of using Rayner's toric IOLs.

New tricks

Breaking news from Day 3 of ESCRS

New at congress, Zeiss Toric Solution is a combination of tools to allow physicians to implant and align toric lenses faster and easier.

Geuder has launched the Megatron S4 system, an upgrade on the company?s Megatron S3, which has sold 700 units worldwide since its launch in 2001. “The launch of the S4 marks the successful end of about three years work,”said Dirk Mittnacht, product manager systems for Geuder.